jengstrand

Consultant surgeon @KarolinskaUnsju @hpbkarolinska Associate Professor @karolinskainst

[jengstrand @jengstrand]

Final Call: Share Your Expertise on Synchronous CRLM 🌍

HPB and colorectal surgeons
We need your input on treatment strategies, current practice and challenges

🕝 One week left

Link 👉 https://t.co/MlRpjIDk8L

@sparrelid @ksoreide @EAHPBA @IHPBA
#colorectal #HPB

[E-AHPBA @EAHPBA]

Join us this Thursday!
🔗 Register now: https://t.co/CqaDy1lewt

[E-AHPBA @EAHPBA]

🚨 Join the next E-AHPBA Grand Rounds!
📅 Thursday 23rd October 2025, 18:00 CET
🎯 Topic: Colorectal Liver Metastases
🧑‍⚕️ Speakers: Rene Adam @IHPBA President, Sheraz Yaqub & Jennie Engstrand
#MedicalEducation
Don’t miss this session in the E-AHPBA Online Academy Certificate Programme — attend 70% of sessions live (2025–2027) to earn your official certificate!

🔗 Register now: https://t.co/d7DBEoYQAR

#EAHPBA #Surgery #LiverMetastases #Hepatobiliary

[Ernesto Sparrelid @sparrelid]

Please help us better understand current management of synchronous CRLM by taking this @EAHPBA endorsed survey by @jengstrand from @HpbKarolinska

A special plea to our colorectal surgeon & GI onc colleagues, help us disseminate this in your network

👉 https://t.co/UsfgZuBjrr

[Ernesto Sparrelid @sparrelid]

Do you recognize ciliated hepatic foregut cysts (CHFC) at your center? For you who do, what is your treatment policy?

Full article: Ciliated hepatic foregut cysts: a large retrospective single-centre series https://t.co/SGoTEfjn30

@dr_gilgson @jengstrand @HpbKarolinska @hpb_so

[BJS Open @BjsOpen]

Importance of resection margin after resection of colorectal liver metastases in the era of modern chemotherapy: population-based cohort study
➡️https://t.co/AEip7ys0tL

This national study examines how resection margins of 0.0 mm, 0.1–0.9 mm and ≥1 mm influence overall survival in patients resected for colorectal liver metastasis in an era of modern perioperative chemotherapy, analysing data from the national registries SweLiv and SCRCR. Despite modern chemotherapy the resection margin is still an important factor for the survival of patients resected for colorectal liver metastasis, and a margin of ≥1 mm is needed to achieve the best possible outcome.

👏👏👏Emil Östrand, Jenny Rystedt, Jennie Engstrand, Petter Frühling, Oskar Hemmingsson, Per Sandström, Malin Sternby Eilard, Bobby Tingstedt, @PamelaBuchwald

#SoMe4Surgery #MedTwitter #SurgEd #Surgery @me4_so @BJSAcademy @BJSurgery @young_bjs @juliomayol @JJEarnshaw @OUPMedicine #some4hpb #some4tpl @hpb_so
#liversurgery #CRLM #colorectalsurgery #colorectalcancer @FightCRC #StepUp4CRC

[PancreasGroup.org @PancreasGroup]

🚨https://t.co/ogKjVuJEID 2
💡Survey on Hospital Factors Affecting Failure to Rescue in Pancreatic Surgery

Participate now!
👉https://t.co/wYFpvyqMut

✅ Complete the online Survey ⏰10min
✅ Stay anonymous
✅ No need for ethics approval
✅ PubMed citable co-authorship

[jengstrand @jengstrand]

@HannesHagstrom @karolinskainst @KarolinskaUnsju Grattis, så välförtjänt!

[Cancer Cell Invasion lab @Cancer_Invasion]

Why are some metastases more aggressive than others?
In a new manuscript, we got a little closer to the answer by taking a good look at the fibrotic capsule that surrounds some liver metastases - this one is really close to the lab's heart! 1/8:
https://t.co/Mc2GqyoOzS

[BJS @BJSurgery]

Comparing the accuracy of prediction models to detect clinically relevant post-hepatectomy liver failure early after major hepatectomy
➡️ https://t.co/Ohqe4SHFs7

Arterial lactate measurements were recently suggested as an early predictor of clinically relevant post-hepatectomy liver failure (PHLF), but in the subgroup of major liver resections a more comprehensive approach is needed.
1⃣In a cohort of 649 major hepatectomy patients, lactate on postoperative day (POD) 1 (AUC 0.75) was outperformed by both clinical risk factors (AUC 0.81, P < 0.05) and bilirubin POD1 (AUC 0.83, P < 0.05) in predicting clinically relevant PHLF grade B/C as defined by the International Study Group of Liver Surgery (ISGLS).
2⃣A multivariable logistic regression model including five clinical risk factors and bilirubin POD1 (AUC 0.87 (P < 0.01)) was developed to predict PHLF grade B/C in major hepatectomy already on POD1, with an equally good discriminatory potential for 90-day mortality as the established ISGLS criteria.

Great work by Ruth Baumgartner, Jennie Engstrand, Patric Rajala, Jonathan Grip, Poya Ghorbani, Ernesto Sparrelid, Stefan Gilg

#SoMe4Surgery #MedTwitter #SurgEd #Surgery #some4hpb #some4tpl @DPCG_official @pancreatitis_nl @P_C_E_ @dice_europe @BJSAcademy @young_bjs

[jengstrand @jengstrand]

@Cancer_Invasion @sparrelid @HpbKarolinska

[Karolinska Institutet @karolinskainst]

@NatureComms @Cancer_Invasion Link to publication ⬇️
https://t.co/bFFMkOyXWX

[Ernesto Sparrelid @sparrelid]

Superb defence today by Pascale Tinguely! @karolinskainst Great opposition and discussion by @AAFretland from @Oslounivsykehus @jengstrand from @HpbKarolinska part of the supervisor group. Important work on MWA for CRLM @hpb_so @EAHPBA

[Åsmund A. Fretland @AAFretland]

Ablation on the big stage #eahpba2023. Jacob Freedman @Danderydssjukh @karolinskainst with a solid overview. Great discussion by @VautheyMD. RCTs are coming! @jengstrand @PascalePasci central in the scientific work! @sparrelid @dr_gilgson @EAHPBA

[jengstrand @jengstrand]

💎 MAVERRIC trial is out 💎

Stereotactic MWA, a valid treatment option for resectable CRLM?

🇸🇪🇳🇱🇨🇭98 patients
🤜🤛 SMWA vs HR
👍 equal 3yr survival
⬇️ morbidity

@PascalePasci

AddThis | Home https://t.co/cLLf34Ws0X

[BJS Open @BjsOpen]

#ICYMI: Popular BJSOpen papers online in 2022

July:
Post-hepatectomy liver failure &amp; survival
🧑‍🤝‍🧑799 pts/27% liver failure
Grade A PHLF 🔼comps, no impact on 90d mortality
Grade B/C 🔼90day mortality
Survive to 90 days, no longterm impact

#some4surgery
https://t.co/59pXZGFc0u

[Ernesto Sparrelid @sparrelid]

Attention @hpb_so #some4HPB! Our second HPB fellowship @HpbKarolinska @KarolinskaUnsju @karolinskainst is now ready for applicants. Deadline December 15, starting in September 2023. Current fellow is @Giampaolo_Perri from @PancreasVerona

[European Journal of Surgical Oncology @ejsotweets]

Ablation versus resection for resectable colorectal liver metastases - Health care related cost and survival analyses from a quasi-randomised study
#MAVERRIC trial

@karolinskainst @researchumcg

@ESSOnews @AHPBA @OncologyAdvance @deLiguoriCarino @hpb_so

https://t.co/Cc2dkKxBxo

[jengstrand @jengstrand]

MWA 🤜🤛Liver resection for resectable CRLM 🌸equal 5yr OS 🌸morbidity &amp; LOS ⬇️ following MWA 🌸💸⬇️ after MWA ⚠️small study: egarly awaiting results from RCT https://t.co/ENcYxJnIzI

[Cancer Cell Invasion lab @Cancer_Invasion]

Guess what we are working on now!
Big thanks to all diligent scientists, clinicians &amp; collaborators involved, @sparrelid @jengstrand @AndreaCdelVall1 @HonigNatalie @Juniperan, Peter Vermeulen, Carlos Fernández Moro et al (not on twitter)! 8/8

[Ernesto Sparrelid @sparrelid]

Glad to present our new HPB fellowship @HpbKarolinska Deadline for applying to the first fellowship starting september 2022 is February 13. Please follow the link below for more details and share with retweet. @karolinskainst @KarolinskaUnsju @hpb_so

https://t.co/2AFPcQ1Yp9